Moderna and CEPI Partner to Develop Bundibugyo Ebolavirus Vaccine

Moderna and CEPI are expanding their collaboration to develop a potential vaccine against the Bundibugyo ebolavirus. The collaboration aims to advance the development of a vaccine.

The expanded partnership builds upon an existing relationship between Moderna and CEPI. The two organizations will work together to develop and test a vaccine candidate, with the goal of providing a tool to combat the Bundibugyo ebolavirus. The specific details of the expanded collaboration, including financial commitments and timelines, were not disclosed in the announcement.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 1, 2026

Author

GOAI